Organigram Global
Produces indoor-grown cannabis for Canadian patients and adult-use consumers under a multi-brand portfolio.
Something off on this page? Send us feedback.
Profile
Sells indoor-grown cannabis for Canadian patients and adult-use consumers through a multi-brand portfolio. Cultivation, processing and manufacturing support flower, pre-rolls, vapes, edibles, concentrates and beverages, while Sanity Group extends the platform into German medical cannabis.
Indoor cultivation and a consumer-oriented portfolio supply Canadian medical patients and adult-use channels. Edison, SHRED, Big Bag O' Buds and Collective Project span flower, pre-rolls, vapes, edibles, concentrates and beverages. Facilities in New Brunswick, Québec, Manitoba and Ontario support cultivation, processing and manufacturing.
Acquisitions broadened confectionery, vaping, infused pre-roll and beverage capabilities, while Sanity Group adds a German medical-cannabis platform with operations across several European markets. The company works with BAT on product development and capital initiatives. Its business operates within Canada's cannabis framework and, after Sanity's acquisition, across additional jurisdictional requirements.
Company facts
Categories
Key statistics
Year to date −29.2% · Average volume (30d) 1.3M
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026Q3 FY26 | −$0.01 | $0.54 | +5,520.0% | $68.2M | $74.5M | +9.2% | +17.14% |
| May 12, 2026Q2 FY26 | −$0.01 | −$0.01 | 0.0% | $50.6M | $43.0M | −15.0% | +0.90% |
| Feb 10, 2026Q1 FY26 | −$0.01 | −$0.02 | −100.0% | $53.3M | $46.3M | −13.1% | −5.76% |
| Dec 16, 2025Q4 FY25 | $0.00 | −$0.20 | — | $50.5M | $57.4M | +13.6% | +7.65% |
Financial highlights
| 12 quarters | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $47.2M | $50.9M | $57.6M | $45.7M | $43.0M | $76.1M | |
| Gross profit | $13.2M | $18.8M | $22.9M | $16.8M | $11.8M | $29.8M | |
| Operating income | −$5.5M | −$1.5M | $855.3K | −$2.5M | −$7.0M | $3.8M | |
| Net income | $30.5M | −$4.5M | −$27.3M | $14.4M | −$662.5K | $75.9M | |
| Diluted EPS | $0.23 | −$0.03 | −$0.20 | $0.11 | −$0.01 | $0.55 | |
| Gross margin | 28.1% | 36.9% | 39.8% | 36.7% | 27.4% | 39.2% | |
| Operating margin | -11.6% | -3.0% | 1.5% | -5.4% | -16.4% | 5.0% |
Fiscal years (4-quarter sums)FY21 $56.9M · FY22 $104.9M · FY23 $116.3M · FY24 $115.0M · FY25 $186.4M
Revenue by product · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $8.4M · Total debt $15.1M · Total assets $590.0M · Shareholders' equity $400.3M
Dividends
No dividends on record.
Ownership
Shares outstanding 140.78M · Float 93.69M · 66.6% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BT DE Investments Inc. | 42.23M | 29.90% | 13D | Apr 17, 2026 |
| Toroso Investments, LLC | 2.16M | 1.54% | 13F | Aug 13, 2026 |
| Renaissance Technologies LLC | 1.44M | 1.03% | 13F | Aug 13, 2026 |
| Advisorshares Investments LLC | 888.1K | 0.63% | 13F | Aug 11, 2026 |
| Goldman Sachs Group Inc | 611.5K | 0.43% | 13F | Aug 14, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
View detailsPeers
- Tilray Brands
Canadian adult-use flower and pre-roll brands overlap broadly
- Canopy Growth
Canadian adult-use vapes and infused pre-rolls from national brands
- Cronos Group
Canadian branded flower, edibles and infused pre-rolls
- Consumer Discretionary Select Sector SPDR ETF
Canadian adult-use flower, pre-rolls and vapes under Back Forty
- Deutsche Bank
Canadian vapes, pre-rolls and premium flower under leading brands
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Organigram Global | $1.20 | −1.99% | $171.0M | 2.7 | 49.6 | 0.7 | +43.3% |
| Tilray Brands | $4.59 | +0.17% | $513.3M | — | — | 0.4 | +25.5% |
| Canopy Growth | $0.9900 | −1.88% | $421.9M | — | — | 0.8 | +8.4% |
| Cronos Group | $3.38 | +0.14% | $1.26B | 18.7 | 56.3 | 7.0 | +63.8% |
| Consumer Discretionary Select Sector SPDR ETF | $117.26 | +0.06% | $22.72B | — | — | — | — |
| Deutsche Bank | $40.13 | −0.55% | $75.84B | 10.4 | 8.7 | 1.1 | +23.8% |
| Median | 14.5 | 32.5 | 0.9 | +24.7% |